$RENB
RENOVARO INC. Stock $renb

$renb Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000173112224000807 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.999M	$6.452M	$3.796M
YoY Change	69.45%	69.98%	36.04%
% of Gross Profit
Research & Development	$434.5K	$1.087M	$239.1K
YoY Change	-56.11%	354.62%	-80.28%
% of Gross Profit
Depreciation & Amortization	$31.13K	$30.31K	$28.24K
YoY Change	55.65%	7.3%	-10.96%
% of Gross Profit
Operating Expenses	$5.464M	$17.19M	$4.063M
YoY Change	37.64%	323.06%	0.72%
Operating Profit		-$17.19M	-$4.063M
YoY Change		323.06%	0.72%
Interest Expense	-$1.685M	$303.8K	$122.3K
YoY Change	547.98%	148.43%	-239.09%
% of Operating Profit
Other Income/Expense, Net	$4.241M	$166.4K	-$264.9K
YoY Change		-162.84%	-87.26%
Pretax Income	-$15.73M	-$17.02M	-$4.328M
YoY Change	-32.19%	293.33%	-30.21%
Income Tax
% Of Pretax Income
Net Earnings	-$15.73M	-$17.02M	-$4.328M
YoY Change	-32.19%	293.33%	-30.21%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.16	-$0.08
Diluted Earnings Per Share	-$0.11	-$0.16	-$0.08
COMMON SHARES
Basic Shares Outstanding	147.5M shares	143.7M shares	55.71M shares
Diluted Shares Outstanding		107.5M shares	55.97M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$220.5K	$312.7K	$2.948M
YoY Change	-88.4%	-89.39%	-73.56%
Cash & Equivalents	$220.5K	$312.7K	$2.948M
Short-Term Investments
Other Short-Term Assets	$668.9K	$907.2K	$978.9K
YoY Change	-4.44%	-7.32%	79.7%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.998M	$1.220M	$3.927M
YoY Change	-22.13%	-68.93%	-66.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$482.1K	$488.9K	$529.3K
YoY Change	-5.28%	-7.62%	-71.68%
Goodwill	$159.3M	$164.2M	$11.64M
YoY Change	1268.82%	1310.54%
Intangibles			$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$160.6M	$210.6M	$74.27M
YoY Change	190.89%	183.5%	341549.26%
Total Long-Term Assets	$161.1M	$211.1M	$74.80M
YoY Change	189.1%	182.15%	-55.58%
TOTAL ASSETS
Total Short-Term Assets	$1.998M	$1.220M	$3.927M
Total Long-Term Assets	$161.1M	$211.1M	$74.80M
Total Assets	$163.1M	$212.3M	$78.73M
YoY Change	179.81%	169.63%	-56.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.449M	$7.991M	$4.471M
YoY Change	78.28%	78.71%	818.1%
Accrued Expenses	$5.311M	$3.755M	$593.7K
YoY Change	634.45%	532.44%	-20.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.451M	$7.119M	$6.001M
YoY Change	-46.72%	18.64%	24.97%
Total Short-Term Liabilities	$30.31M	$20.87M	$11.77M
YoY Change	174.97%	77.3%	56.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$231.4K	$20.03M	$829.2K
YoY Change	25.25%	2316.15%	-92.69%
Total Long-Term Liabilities	$842.4K	$22.81M	$829.2K
YoY Change	8.61%	2650.77%	-92.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.31M	$20.87M	$11.77M
Total Long-Term Liabilities	$842.4K	$22.81M	$829.2K
Total Liabilities	$31.15M	$43.68M	$12.60M
YoY Change	164.03%	246.63%	-33.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$324.7M	-$274.8M	-$220.8M
YoY Change	33.05%	24.42%
Common Stock	$15.50K	$14.75K	$5.800K
YoY Change	143.35%	154.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$132.0M	$168.6M	$66.13M
YoY Change
Total Liabilities & Shareholders Equity	$163.1M	$212.3M	$78.73M
YoY Change	179.81%	169.63%	-56.29%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$15.73M	-$17.02M	-$4.328M
YoY Change	-32.19%	293.33%	-30.21%
Depreciation, Depletion And Amortization	$31.13K	$30.31K	$28.24K
YoY Change	55.65%	7.3%	-10.96%
Cash From Operating Activities	-$2.414M	-$2.634M	-$3.308M
YoY Change	6.8%	-20.38%	18.78%
INVESTING ACTIVITIES
Capital Expenditures	$23.55K	$5.300K	$0.00
YoY Change	135.5%
Acquisitions
YoY Change
Other Investing Activities	-$29.82K	-$86.30K
YoY Change
Cash From Investing Activities	-$53.37K	-$91.60K	$0.00
YoY Change	433.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.467M	2.641M	2.109M
YoY Change	97.34%	25.25%	818.67%
NET CHANGE
Cash From Operating Activities	-2.414M	-2.634M	-3.308M
Cash From Investing Activities	-53.37K	-91.60K	0.000
Cash From Financing Activities	2.467M	2.641M	2.109M
Net Change In Cash	-430.0	-84.36K	-1.199M
YoY Change	-99.96%	-92.97%	-53.07%
FREE CASH FLOW
Cash From Operating Activities	-$2.414M	-$2.634M	-$3.308M
Capital Expenditures	$23.55K	$5.300K	$0.00
Free Cash Flow	-$2.437M	-$2.639M	-$3.308M
YoY Change	7.37%	-20.22%	18.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	RENB	Restricted Shares Issued For Advisory Services RestrictedSharesIssuedForAdvisoryServices		usd
CY2024Q1	RENB	Preferred Stock Converted To Common Stock Pursuant To Acquisition Of Gedi Cube PreferredStockConvertedToCommonStockPursuantToAcquisitionOfGediCube		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38758
	dei	Entity Registrant Name EntityRegistrantName	Renovaro Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2559340
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2080 Century Park East
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 906
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90067
	dei	City Area Code CityAreaCode	305
	dei	Local Phone Number LocalPhoneNumber	918-1980
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	RENB
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	147504944	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	312697	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	907218	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	690925	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1219915	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	2565405	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	488915	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508989	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31042	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	39676	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	44945255	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	42611000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	164186852	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	21742	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1385619	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	210570510	usd
CY2024Q1	us-gaap	Assets Assets	212279340	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	7990631	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3754976	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	519427	usd
CY2024Q1	RENB	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	1006438	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	483226	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	193422	usd
CY2024Q1	RENB	Notes Payable Net NotesPayableNet	3418621	usd
CY2023Q2	RENB	Notes Payable Net NotesPayableNet	4624947	usd
CY2024Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3700694	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20874013	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	970353	usd
CY2024Q1	RENB	Contingent Consideration Liability Noncurrent ContingentConsiderationLiabilityNoncurrent	19064562	usd
CY2023Q2	RENB	Contingent Consideration Liability Noncurrent ContingentConsiderationLiabilityNoncurrent	0	usd
CY2024Q1	RENB	Deferred Tax Liability Non Current DeferredTaxLiabilityNonCurrent	2774856	usd
CY2023Q2	RENB	Deferred Tax Liability Non Current DeferredTaxLiabilityNonCurrent	0	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22809771	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	775587	usd
CY2024Q1	us-gaap	Liabilities Liabilities	43683784	usd
CY2023Q2	us-gaap	Liabilities Liabilities	11798685	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	147488598	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147488598	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63698144	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63698144	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	14750	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	6371	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	442304652	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	290554875	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274757816	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-244029253	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1033970	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-29882	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	168595556	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	46502111	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	212279340	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58300796	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7652379	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3796057	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19558981	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12365960	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1087156	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	239137	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2274321	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3170471	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8421000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8421000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30305	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28242	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	90727	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	85487	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	17190840	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4063436	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-30345029	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15621918	usd
CY2024Q1	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	486500	usd
CY2023Q1	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	usd
	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	486500	usd
	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	usd
CY2024Q1	RENB	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	0	usd
CY2023Q1	RENB	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	0	usd
	RENB	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	-120018	usd
	RENB	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-419182	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	303802	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	122289	usd
	us-gaap	Interest Expense InterestExpense	758057	usd
	us-gaap	Interest Expense InterestExpense	310766	usd
CY2024Q1	RENB	Interest And Other Income Expense InterestAndOtherIncomeExpense	-16272	usd
CY2023Q1	RENB	Interest And Other Income Expense InterestAndOtherIncomeExpense	-142571	usd
	RENB	Interest And Other Income Expense InterestAndOtherIncomeExpense	8041	usd
	RENB	Interest And Other Income Expense InterestAndOtherIncomeExpense	-133938	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	166426	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-264860	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-383534	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-863886	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-17024414	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4328296	usd
	us-gaap	Net Income Loss NetIncomeLoss	-30728563	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16485804	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107480475	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107480475	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55974605	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55974605	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79168663	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79168663	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55524511	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55524511	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-17024414	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4328296	usd
	us-gaap	Net Income Loss NetIncomeLoss	-30728563	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16485804	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1061201	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2110	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1063852	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1949	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15963213	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4330406	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29664711	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16487753	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	46502111	usd
CY2023Q3	RENB	Issuance Of Preferred Stock And Warrants In Private Placement IssuanceOfPreferredStockAndWarrantsInPrivatePlacement	2000000	usd
CY2023Q3	RENB	Issuance Of Preferred Stock And Warrants For Conversion Of Note Payable IssuanceOfPreferredStockAndWarrantsForConversionOfNotePayable	2000001	usd
CY2023Q3	RENB	Restricted Shares Issued For Services Rendered Value RestrictedSharesIssuedForServicesRenderedValue	4470000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	983829	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9175028	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-34601	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	46746312	usd
CY2023Q4	RENB	Stock Issued Pursuant To Warrants Exercised Value StockIssuedPursuantToWarrantsExercisedValue	341865	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	999228	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-4529121	usd
CY2023Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	37252	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	43595536	usd
CY2024Q1	RENB	Noncash Exercise Of Warrants Value NoncashExerciseOfWarrantsValue	2000000	usd
CY2024Q1	RENB	Restricted Shares Issued For Services Rendered Value RestrictedSharesIssuedForServicesRenderedValue	100000	usd
CY2024Q1	RENB	Issuance Of Common Stock Under Private Placement Offering IssuanceOfCommonStockUnderPrivatePlacementOffering	1000000	usd
CY2024Q1	RENB	Issuance Of Common Stock Pursuant To Acquisition Of Gedi Cube IssuanceOfCommonStockPursuantToAcquisitionOfGediCube	136001631	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1861601	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-17024414	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1061201	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	168595556	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	72618848	usd
CY2022Q3	RENB	Stock Issued Pursuant To Warrants Exercised Value StockIssuedPursuantToWarrantsExercisedValue	1625000	usd
CY2022Q3	RENB	Contingent Shares Issued Pursuant To Acquisition Agreement ContingentSharesIssuedPursuantToAcquisitionAgreement	2762500	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1026008	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-7699760	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-7754	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	70324842	usd
CY2022Q4	RENB	Shares Issued In Lieu Of Interest On Notes Payable Extension SharesIssuedInLieuOfInterestOnNotesPayableExtension	204392	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	819955	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-4457748	usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7915	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	66899356	usd
CY2023Q1	RENB	Shares And Warrants Issued Pursuant To Private Placement Offering SharesAndWarrantsIssuedPursuantToPrivatePlacementOffering	2483000	usd
CY2023Q1	RENB	Restricted Shares Issued For Services Rendered Value RestrictedSharesIssuedForServicesRenderedValue	108000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	968203	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4328296	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2110	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	66128153	usd
	us-gaap	Net Income Loss NetIncomeLoss	-30728563	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16485804	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	90727	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	85487	usd
	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	486500	usd
	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-0	usd
	RENB	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	-120018	usd
	RENB	Loss On Extinguishment Of Debt LossOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-419182	usd
	RENB	Non Cash Compensation NonCashCompensation	3844658	usd
	RENB	Non Cash Compensation NonCashCompensation	2922166	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8421000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	RENB	Restricted Shares For Services Rendered RestrictedSharesForServicesRendered	4570000	usd
	RENB	Restricted Shares For Services Rendered RestrictedSharesForServicesRendered	0	usd
	RENB	Amortization Of Discount On Note Payable AmortizationOfDiscountOnNotePayable	494809	usd
	RENB	Amortization Of Discount On Note Payable AmortizationOfDiscountOnNotePayable	223863	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-0	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-46	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-798741	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-689273	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2110232	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3069487	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2194293	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-407433	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-18520	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	12936	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10684	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8557649	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9512937	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1225779	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	65851	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46878	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23633	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1206806	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23633	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3645000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	RENB	Repayment Of Finance Agreement RepaymentOfFinanceAgreement	646128	usd
	RENB	Repayment Of Finance Agreement RepaymentOfFinanceAgreement	840992	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3000000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2483000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1710000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	341865	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1625000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8050737	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3267008	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	151935	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45462	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1561783	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6224100	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874480	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9172142	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	312697	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2948042	usd
	us-gaap	Interest Paid Net InterestPaidNet	12692	usd
	us-gaap	Interest Paid Net InterestPaidNet	43627	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	RENB	Finance Agreement Entered Into In Exchange For Prepaid Assets FinanceAgreementEnteredIntoInExchangeForPrepaidAssets	906834	usd
	RENB	Finance Agreement Entered Into In Exchange For Prepaid Assets FinanceAgreementEnteredIntoInExchangeForPrepaidAssets	1139875	usd
	RENB	Shares In Lieu Of Interest On Million Notes Payable Extension SharesInLieuOfInterestOnMillionNotesPayableExtension	0	usd
	RENB	Shares In Lieu Of Interest On Million Notes Payable Extension SharesInLieuOfInterestOnMillionNotesPayableExtension	204392	usd
	RENB	Common Shares Issued For Contingent Earn Out Liability CommonSharesIssuedForContingentEarnOutLiability	0	usd
	RENB	Common Shares Issued For Contingent Earn Out Liability CommonSharesIssuedForContingentEarnOutLiability	2762500	usd
	RENB	Conversion Of Note Payable For Issuance Of Preferred Stock ConversionOfNotePayableForIssuanceOfPreferredStock	2000001	usd
	RENB	Conversion Of Note Payable For Issuance Of Preferred Stock ConversionOfNotePayableForIssuanceOfPreferredStock	0	usd
	RENB	Common Shares Issued Upon Acquisition CommonSharesIssuedUponAcquisition	136001631	usd
	RENB	Common Shares Issued Upon Acquisition CommonSharesIssuedUponAcquisition	0	usd
	RENB	Contingent Consideration Issued Upon Acquisition ContingentConsiderationIssuedUponAcquisition	20557500	usd
	RENB	Contingent Consideration Issued Upon Acquisition ContingentConsiderationIssuedUponAcquisition	0	usd
	RENB	Note Payable Settled Through Noncash Exercise Of Warrants NotePayableSettledThroughNoncashExerciseOfWarrants	2000000	usd
	RENB	Note Payable Settled Through Noncash Exercise Of Warrants NotePayableSettledThroughNoncashExerciseOfWarrants	0	usd
	RENB	Debt Discount Related To Convertible Promissory Notes DebtDiscountRelatedToConvertiblePromissoryNotes	301841	usd
	RENB	Debt Discount Related To Convertible Promissory Notes DebtDiscountRelatedToConvertiblePromissoryNotes	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z88u4w3CaEm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><b><span id="xdx_862_z5kSJPu3qbC8">Accounting Estimates</span> –</b> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated. Significant estimates include the fair value of assets acquired in a business acquisition, contingent consideration, and equity instruments issued for goods or services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zxt4qLgRzvYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><b><span id="xdx_862_z6UZRiCn9452">Concentration of Credit Risk</span> –</b> Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, exceed the amount of deposit insurance provided within the relevant jurisdiction where the deposits are held. As of March 31, 2024 and June 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> </p>
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1087156	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2274321	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	239137	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3170471	usd
CY2024Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1861601	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	3844658	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1076203	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	2922166	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-17024414	usd
	us-gaap	Net Income Loss NetIncomeLoss	-30728563	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	312697	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274757816	usd
CY2024Q1	RENB	Working Capital Deficit WorkingCapitalDeficit	19654098	usd
	RENB	Issuance Of Common Stock Pursuant To Acquisition Of Gedi Cube Share IssuanceOfCommonStockPursuantToAcquisitionOfGediCubeShare	70834183	shares
CY2024Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	20557500	usd
CY2024Q1	RENB	Share Acquisition Contingent Consideration ShareAcquisitionContingentConsideration	8474146	shares
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1036909	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	973788	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	547994	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	464799	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	488915	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	508989	usd
CY2024Q1	us-gaap	Depreciation Depreciation	29526	usd
	us-gaap	Depreciation Depreciation	83203	usd
CY2023Q1	us-gaap	Depreciation Depreciation	26662	usd
	us-gaap	Depreciation Depreciation	80915	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31042	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	39676	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	779	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7524	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1580	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4572	usd
CY2023Q2	RENB	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	39676	usd
	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	0	usd
	RENB	Net Definitelife Intangible Assets Amortization NetDefinitelifeIntangibleAssetsAmortization	-7524	usd
	RENB	Net Definitelife Intangible Assets Impairment NetDefinitelifeIntangibleAssetsImpairment	0	usd
	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-1110	usd
CY2024Q1	RENB	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	31042	usd
CY2023Q2	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	54251000	usd
	RENB	Total Indefinite Life Intangible Assets And Goodwill Additions TotalIndefiniteLifeIntangibleAssetsAndGoodwillAdditions	162220535	usd
	RENB	Total Indefinite Life Intangible Assets And Goodwill Amortization TotalIndefiniteLifeIntangibleAssetsAndGoodwillAmortization	0	usd
	RENB	Total Indefinite Life Intangible Assets And Goodwill Impairment TotalIndefiniteLifeIntangibleAssetsAndGoodwillImpairment	-8421000	usd
	RENB	Total Indefinite Life Intangible Assets And Goodwill Translation Adjustment TotalIndefiniteLifeIntangibleAssetsAndGoodwillTranslationAdjustment	1081572	usd
CY2024Q1	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	209132107	usd
CY2023Q2	us-gaap	Liabilities Subject To Compromise Early Contract Termination Fees LiabilitiesSubjectToCompromiseEarlyContractTerminationFees	175000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1942	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9700	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9700	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9700	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31042	usd
CY2017Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	On November 13, 2017, Renovaro entered into a Lease Agreement for a term of five years and two months from November 1, 2017, with Plaza Medical Office Building, LLC, a California limited liability company, as landlord, (the “Landlord”) pursuant to which the Company agreed to lease from the Landlord approximately 2,325 rentable square feet. The base rent increased by 3% each year and ranged from approximately $8,719 per month for the first year to $10,107 per month for the two months of the sixth year. The lease was terminated early without penalties or additional costs as of September 30, 2022, that released an accrual of $70,800 related to leasehold improvements that was not utilized.
CY2018Q2	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	On June 19, 2018, Renovaro entered into a Lease Agreement for a term of ten years from September 1, 2018, with Century City Medical Plaza Land Co., Inc., pursuant to which the Company agreed to lease approximately 2,453 rentable square feet. On February 20, 2019, Renovaro entered into an Addendum to the original Lease Agreement with an effective date of December 1, 2019, where it expanded the lease area to include another 1,101 square feet for a total rentable 3,554 square feet. The base rent increases by 3% each year, and ranges from $17,770 per month for the first year to $23,186 per month for the tenth year. The equalized monthly lease payment for the term of the lease is $20,050.
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M7D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0516	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	286252	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	557851	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	349204	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	309491	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	59439	usd
CY2024Q1	RENB	Lessee Operating Lease Liability Sub Total Amount LesseeOperatingLeaseLiabilitySubTotalAmount	-1562237	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	108658	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1453579	usd
CY2022Q2	us-gaap	Lessee Finance Sublease Residual Value Guarantee Description LesseeFinanceSubleaseResidualValueGuaranteeDescription	On June 20, 2022, the Company entered into a sublease Agreement with One Health Labs (the “Subtenant”), whereby the Subtenant agreed to lease 3,554 square feet of space currently rented by the Company in Century City Medical Plaza as of June 25, 2022, for a period of 3.5 years with an option to renew for the remaining term of the lease that ends as of June 19, 2028. The base rent was $17,770 per month plus $750 towards utility fees that are part of the original lease agreement and would increase by 3% each year over the term of the sublease. The Company received a total of $57,022 on July 1, 2022 after execution of the sublease to cover the first month rent, utility fee and deposit. The first sublease payment began on August 1, 2022.
CY2023Q2	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	139460	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	35540	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	106790	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	99099	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	236455	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	239759	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	-0	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	53310	usd
	us-gaap	Sublease Income SubleaseIncome	-0	usd
	us-gaap	Sublease Income SubleaseIncome	159930	usd
CY2024Q1	RENB	Operating Leases Rent Expenses Net OperatingLeasesRentExpensesNet	-106790	usd
CY2023Q1	RENB	Operating Leases Rent Expenses Net OperatingLeasesRentExpensesNet	-45789	usd
	RENB	Operating Leases Rent Expenses Net OperatingLeasesRentExpensesNet	-236455	usd
	RENB	Operating Leases Rent Expenses Net OperatingLeasesRentExpensesNet	-79829	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	108441	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	232237	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	98950	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	339993	usd
	RENB	Operating Lease Expenses OperatingLeaseExpenses	79829	usd
CY2023Q1	RENB	Cash Paid For The Termination Of Lease CashPaidForTheTerminationOfLease	339993	usd
	RENB	Accrual Payments Related To Termination Of Lease AccrualPaymentsRelatedToTerminationOfLease	77242	usd
	RENB	Repayment On Finance Agreement RepaymentOnFinanceAgreement	646128	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	303802	usd
	us-gaap	Interest Expense Other InterestExpenseOther	758057	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	122289	usd
	us-gaap	Interest Expense Other InterestExpenseOther	310766	usd
CY2024Q1	RENB	Common Stocks Shares Authorized CommonStocksSharesAuthorized	350000000	shares
CY2023Q2	RENB	Common Stocks Shares Authorized CommonStocksSharesAuthorized	350000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	147488598	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147488598	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63698144	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63698144	shares
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	20000000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	525945	shares
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	341865	usd
CY2024Q1	RENB	Issuance Of Common Stock Under Private Placement Offering IssuanceOfCommonStockUnderPrivatePlacementOffering	344827	usd
CY2024Q1	RENB	Common Stock Par Value Private Placement CommonStockParValuePrivatePlacement	0.0001
CY2024Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	50000	shares
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17414	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17414	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	0	shares
	us-gaap	Stock Issued During Period Shares Period Increase Decrease StockIssuedDuringPeriodSharesPeriodIncreaseDecrease	0	shares
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	886849	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	579305	usd
CY2019Q4	RENB	Upfront Payment UpfrontPayment	10000000	usd
CY2019Q4	RENB	Payment For Expenditures PaymentForExpenditures	760000	usd
CY2021Q3	RENB	Initial Payment InitialPayment	600000	usd
CY2021Q3	RENB	Initial Payment InitialPayment	600000	usd
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17414	shares
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	0	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-33622997	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-000807-index-headers.html	Edgar Link	pending
0001731122-24-000807-index.html	Edgar Link	pending
0001731122-24-000807.txt	Edgar Link	pending
0001731122-24-000807-xbrl.zip	Edgar Link	pending
e5659_10q.htm	Edgar Link	pending
e5659_ex31-1.htm	Edgar Link	pending
e5659_ex31-2.htm	Edgar Link	pending
e5659_ex32-1.htm	Edgar Link	pending
e5659_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
e5659_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
renb-20240331.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
renb-20240331_cal.xml	Edgar Link	unprocessable
renb-20240331_def.xml	Edgar Link	unprocessable
renb-20240331_lab.xml	Edgar Link	unprocessable
renb-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RENB
RENOVARO INC. Stock $renb

2024 Q2 Form 10-Q Financial Statement

#000173112224000807 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RENB RENOVARO INC. Stock $renb

2024 Q2 Form 10-Q Financial Statement

#000173112224000807 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RENB
RENOVARO INC. Stock $renb